We then evaluated the impact of the pharmacological inhibition of CBP/β-catenin interaction on the persistent viral reservoir by measuring by PCR the frequency of infection of CD4+ T cell subsets sorted by fluorescence-activated cell sorting (FACS) from the peripheral blood. The gene discussed is CREBBP; the disease is infection.